PARIS (Bloomberg): Hydroxychloroquine, the 65-year-old malaria drug that US President Donald Trump has praised, appeared not to help patients get rid of the pathogen in a small study.
The pill did not help patients clear the virus better than standard care and was much more likely to cause side effects, according to a study of 150 hospitalised patients by doctors at 16 centres in China. The research, which has not been peer-reviewed, was released on Tuesday (April 14).
